Genetic alterations and their clinical implications in older patients with acute myeloid leukemia CH Tsai, HA Hou, JL Tang, CY Liu, CC Lin, WC Chou, MH Tseng, ... Leukemia 30 (7), 1485-1492, 2016 | 128 | 2016 |
Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia HA Hou, CY Liu, YY Kuo, WC Chou, CH Tsai, CC Lin, LI Lin, MH Tseng, ... Oncotarget 7 (8), 9084, 2016 | 93 | 2016 |
Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome HA Hou, CH Tsai, CC Lin, WC Chou, YY Kuo, CY Liu, MH Tseng, ... Blood cancer journal 8 (4), 39, 2018 | 88 | 2018 |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax YW Wang, CH Tsai, CC Lin, FM Tien, YW Chen, HY Lin, M Yao, YC Lin, ... Annals of Hematology 99, 501-511, 2020 | 69 | 2020 |
Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome BS Ko, YF Wang, JL Li, CC Li, PF Weng, SC Hsu, HA Hou, HH Huang, ... EBioMedicine 37, 91-100, 2018 | 64 | 2018 |
Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome ME Lin, HA Hou, CH Tsai, SJ Wu, YY Kuo, MH Tseng, MC Liu, CW Liu, ... Clinical epigenetics 10, 1-12, 2018 | 58 | 2018 |
Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia CH Tsai, HA Hou, JL Tang, YY Kuo, YC Chiu, CC Lin, CY Liu, MH Tseng, ... Blood cancer journal 7 (12), 663, 2017 | 54 | 2017 |
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute … FM Tien, HA Hou, CH Tsai, JL Tang, YC Chiu, CY Chen, YY Kuo, ... Blood cancer journal 8 (9), 87, 2018 | 40 | 2018 |
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor‐risk factor in de novo acute myeloid leukemia patients FM Tien, HA Hou, CH Tsai, JL Tang, CY Chen, YY Kuo, CC Li, CT Lin, ... European journal of haematology 101 (1), 86-94, 2018 | 40 | 2018 |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML CH Tsai, JL Tang, FM Tien, YY Kuo, DC Wu, CC Lin, MH Tseng, YL Peng, ... Blood Advances 5 (10), 2456-2466, 2021 | 37 | 2021 |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA FM Tien, HA Hou, JL Tang, YY Kuo, CY Chen, CH Tsai, M Yao, CT Lin, ... haematologica 103 (11), e510, 2018 | 35 | 2018 |
Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125 YH Wang, CC Lin, CL Hsu, SY Hung, CY Yao, SH Lee, CH Tsai, HA Hou, ... Annals of hematology 100, 487-498, 2021 | 29 | 2021 |
Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical Information A Tefferi, N Gangat, M Mudireddy, TL Lasho, C Finke, KH Begna, ... Mayo Clinic Proceedings, 2018 | 28 | 2018 |
Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients CH Tsai, CY Yao, FM Tien, JL Tang, YY Kuo, YC Chiu, CC Lin, MH Tseng, ... EBioMedicine 40, 240-250, 2019 | 27 | 2019 |
The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome YT Yang, YC Chiu, CJ Kao, HA Hou, CC Lin, CH Tsai, MH Tseng, ... Blood Cancer Journal 8 (8), 78, 2018 | 26 | 2018 |
Reduced incidence of interstitial pneumonitis after allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation Y Chiang, CH Tsai, SH Kuo, CY Liu, M Yao, CC Li, SY Huang, BS Ko, ... Scientific reports 6 (1), 1-11, 2016 | 23 | 2016 |
Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemia HA Hou, JW Lu, TY Lin, CH Tsai, WC Chou, CC Lin, YY Kuo, CY Liu, ... Blood cancer journal 7 (7), e588-e588, 2017 | 22 | 2017 |
A 4-gene leukemic stem cell score can independently predict the prognosis of myelodysplastic syndrome patients YH Wang, CC Lin, CY Yao, CL Hsu, HA Hou, CH Tsai, WC Chou, HF Tien Blood Advances 4 (4), 644-654, 2020 | 20 | 2020 |
A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes YH Wang, HA Hou, CC Lin, YY Kuo, CY Yao, CL Hsu, MH Tseng, CH Tsai, ... Blood Advances 5 (22), 4535-4548, 2021 | 19 | 2021 |
Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial Y Song, H Tilly, S Rai, H Zhang, J Jin, H Goto, Y Terui, HJ Shin, WS Kim, ... Blood 141 (16), 1971-1981, 2023 | 15 | 2023 |